{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:07:37Z","timestamp":1793934457941,"version":"4.8.0"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ygyno.2025.03.035","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T01:55:13Z","timestamp":1743731713000},"page":"42-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Understanding frailty and the role of patient-centered care for older adults with gynecologic cancer"],"prefix":"10.1016","volume":"196","author":[{"given":"Stephanie","family":"Cham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanika","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise C.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Lichtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William P.","family":"Tew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ygyno.2025.03.035_bb0005","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1200\/JCO.2008.20.8983","article-title":"Future of cancer incidence in the United States: burdens upon an aging, changing nation","volume":"27","author":"Smith","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.ygyno.2025.03.035_bb0010","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1200\/JCO.2013.55.0418","article-title":"Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations","volume":"32","author":"Hurria","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.ygyno.2025.03.035_bb0015","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1200\/JCO.2014.55.3073","article-title":"Breast and ovarian cancer in the older woman","volume":"32","author":"Tew","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.035_bb0020","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.14694\/EdBook_AM.2015.35.e311","article-title":"Epithelial ovarian cancer in older women: defining the best management approach","author":"Duska","year":"2015","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.ygyno.2025.03.035_bb0025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1200\/EDBK_158668","article-title":"Treatment of older women with endometrial cancer: improving outcomes with personalized care","volume":"35","author":"Duska","year":"2016","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.035_bb0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s43587-020-00017-z","article-title":"The physical frailty syndrome as a transition from homeostatic symphony to cacophony","volume":"1","author":"Fried","year":"2021","journal-title":"Nat. Aging"},{"key":"10.1016\/j.ygyno.2025.03.035_bb0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1100\/tsw.2001.58","article-title":"Accumulation of deficits as a proxy measure of aging","volume":"1","author":"Mitnitski","year":"2001","journal-title":"ScientificWorldJournal"},{"issue":"7","key":"10.1016\/j.ygyno.2025.03.035_bb0040","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/gerona\/62.7.722","article-title":"Frailty in relation to the accumulation of deficits","volume":"62","author":"Rockwood","year":"2007","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"3","key":"10.1016\/j.ygyno.2025.03.035_bb0045","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"5","key":"10.1016\/j.ygyno.2025.03.035_bb0050","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1159\/000211949","article-title":"Frailty syndrome: a transitional state in a dynamic process","volume":"55","author":"Lang","year":"2009","journal-title":"Gerontology"},{"issue":"3","key":"10.1016\/j.ygyno.2025.03.035_bb0055","first-page":"177","article-title":"Clinical definition of sarcopenia","volume":"11","author":"Santilli","year":"2014","journal-title":"Clin. Cases Miner. Bone Metab."},{"issue":"5","key":"10.1016\/j.ygyno.2025.03.035_bb0060","first-page":"362","article-title":"Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology","volume":"67","author":"Ethun","year":"2017","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.ygyno.2025.03.035_bb0065","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1001\/jamaoncol.2021.1160","article-title":"Applying a life course biological age framework to improving the care of individuals with adult cancers: review and research recommendations","volume":"7","author":"Mandelblatt","year":"2021","journal-title":"JAMA Oncol."},{"issue":"24","key":"10.1016\/j.ygyno.2025.03.035_bb0070","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1200\/JCO.2014.55.1432","article-title":"Biology of cancer and aging: a complex association with cellular senescence","volume":"32","author":"Falandry","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.03.035_bb0075","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ygyno.2021.02.027","article-title":"A deficit-accumulation frailty index predicts survival outcomes in patients with gynecologic malignancy","volume":"161","author":"Mullen","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2025.03.035_bb0080","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1200\/OP.20.00442","article-title":"How is geriatric assessment used in clinical practice for older adults with cancer? A survey of cancer providers by the American Society of Clinical Oncology","volume":"17","author":"Dale","year":"2021","journal-title":"JCO Oncol. Pract."},{"issue":"4","key":"10.1016\/j.ygyno.2025.03.035_bb0085","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1634\/theoncologist.2014-0247","article-title":"Geriatric assessment-identified deficits in older cancer patients with normal performance status","volume":"20","author":"Jolly","year":"2015","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.035_bb0090","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejso.2015.12.004","article-title":"The assessment and management of older cancer patients: a SIOG surgical task force survey on surgeons\u2019 attitudes","volume":"42","author":"Ghignone","year":"2016","journal-title":"Eur. J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.035_bb0095","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/jgs.15784","article-title":"AGS report on engagement related to the NIH inclusion across the lifespan policy","volume":"67","author":"Vaughan","year":"2019","journal-title":"J. Am. Geriatr. Soc."},{"issue":"22","key":"10.1016\/j.ygyno.2025.03.035_bb0100","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1200\/JCO.19.02809","article-title":"Defining undertreatment and overtreatment in older adults with cancer: a scoping literature review","volume":"38","author":"DuMontier","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.ygyno.2025.03.035_bb0105","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJMsa012528","article-title":"Understanding the treatment preferences of seriously ill patients","volume":"346","author":"Fried","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.035_bb0110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ygyno.2021.10.081","article-title":"Incidence, treatment, and survival trends in older versus younger women with epithelial ovarian cancer from 2005 to 2018: a nationwide Danish study","volume":"164","author":"Ekmann-Gade","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2025.03.035_bb0115","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/AOG.0000000000001140","article-title":"Management for elderly women with advanced-stage, high-grade endometrial cancer","volume":"126","author":"Rauh-Hain","year":"2015","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.035_bb0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2011.02.040","article-title":"Endometrial cancer in the oldest old: tumor characteristics, patterns of care, and outcome","volume":"122","author":"Wright","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.03.035_bb0125","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ygyno.2019.03.249","article-title":"Determinants of health-related quality of life in elderly ovarian cancer patients: the role of frailty and dependence","volume":"153","author":"de Arruda","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.035_bb0130","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ygyno.2024.08.017","article-title":"Frailty in patients with ovarian cancer and the role of healthcare access, race, and ethnicity","volume":"190","author":"Meernik","year":"2024","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2025.03.035_bb0135","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ageing\/afz088","article-title":"The impact of frailty on healthcare resource use: a longitudinal analysis using the clinical practice research datalink in England","volume":"48","author":"Han","year":"2019","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.035_bb0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ygyno.2020.12.030","article-title":"Preoperative frailty assessment in patients undergoing gynecologic oncology surgery: a systematic review","volume":"161","author":"Di Donato","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.035_bb0145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ygyno.2015.01.532","article-title":"Frailty index predicts severe complications in gynecologic oncology patients","volume":"137","author":"Uppal","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.03.035_bb0150","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ygyno.2022.07.003","article-title":"Preoperative assessment using the five-factor modified frailty index: a call for standardized preoperative assessment and prehabilitation services in gynecologic oncology","volume":"166","author":"AlHilli","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.035_bb0155","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ygyno.2012.04.019","article-title":"Frailty: an outcome predictor for elderly gynecologic oncology patients","volume":"126","author":"Courtney-Brooks","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.03.035_bb0160","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jgo.2020.09.029","article-title":"Can fried frailty score predict postoperative morbidity and mortality in gynecologic cancer surgery? Results of a prospective study","volume":"12","author":"Inci","year":"2021","journal-title":"J. Geriatr. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.035_bb0165","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ygyno.2020.08.024","article-title":"Effect of frailty on postoperative readmissions and cost of care for ovarian cancer","volume":"159","author":"Sia","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.035_bb0170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ygyno.2020.08.022","article-title":"Modified fragility index and surgical complexity score are able to predict postoperative morbidity and mortality after cytoreductive surgery for advanced ovarian cancer","volume":"161","author":"Di Donato","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.035_bb0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ygyno.2022.05.009","article-title":"Frailty repels the knife: the impact of frailty index on surgical intervention and outcomes","volume":"166","author":"Handley","year":"2022","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.035_bb0180","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ygyno.2017.07.126","article-title":"Functional not chronologic age: frailty index predicts outcomes in advanced ovarian cancer","volume":"147","author":"Kumar","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.035_bb0185","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ygyno.2018.12.025","article-title":"Frailty in ovarian cancer identified the need for increased postoperative care requirements following cytoreductive surgery","volume":"153","author":"Yao","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2025.03.035_bb0190","doi-asserted-by":"crossref","first-page":"571 e1","DOI":"10.1016\/j.ajog.2019.02.019","article-title":"Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer","volume":"220","author":"Cham","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.035_bb0195","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ygyno.2021.02.012","article-title":"Frailty index for prediction of surgical outcome in ovarian cancer: results of a prospective study","volume":"161","author":"Inci","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.035_bb0200","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ygyno.2021.05.013","article-title":"Modified frailty index predicts postoperative complications in women with gynecologic cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"162","author":"Chambers","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.035_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2024.102154","article-title":"The modified 5-factor frailty index predicts postoperative outcomes in patients with ovarian cancer undergoing hyperthermic intraperitoneal chemotherapy","volume":"57","author":"Kelley","year":"2024","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.035_bb0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ygyno.2022.11.024","article-title":"Association between CT-based body composition assessment and patient outcomes during neoadjuvant chemotherapy for epithelial ovarian cancer","volume":"169","author":"Wood","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2025.03.035_bb0215","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ejso.2022.02.024","article-title":"Prevalence of computed tomography-based sarcopenia and the prognostic value of skeletal muscle index and muscle attenuation amongst women with epithelial ovarian malignancy: a systematic review and meta-analysis","volume":"48","author":"Tranoulis","year":"2022","journal-title":"Eur. J. Surg. Oncol."},{"issue":"61","key":"10.1016\/j.ygyno.2025.03.035_bb0220","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jncimonographs\/lgad007","article-title":"Muscle loss during cancer therapy is associated with poor outcomes in advanced ovarian cancer","volume":"2023","author":"Polen-De","year":"2023","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.ygyno.2025.03.035_bb0225","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ygyno.2023.11.031","article-title":"Relationship between frailty and nutrition: refining predictors of mortality after primary cytoreductive surgery for ovarian cancer","volume":"180","author":"Chauhan","year":"2024","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2025.03.035_bb0230","first-page":"3673","article-title":"Inflammatory and nutritional serum markers as predictors of peri-operative morbidity and survival in ovarian cancer","volume":"37","author":"Kumar","year":"2017","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.035_bb0235","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2019.08.004","article-title":"Using an evidence-based triage algorithm to reduce 90-day mortality after primary debulking surgery for advanced epithelial ovarian cancer","volume":"155","author":"Narasimhulu","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.035_bb0240","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2021.02.022","article-title":"The effect of frailty on postoperative readmissions, morbidity, and mortality in endometrial cancer surgery","volume":"161","author":"Sia","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.035_bb0245","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2022-003484","article-title":"Frailty is independently associated with worse outcomes and increased resource utilization following endometrial cancer surgery","author":"Nakhla","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.035_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/curroncol32010021","article-title":"Role of age, comorbidity, and frailty in the prediction of postoperative complications after surgery for vulvar cancer: a retrospective cohort study with the development of a nomogram","volume":"32","author":"Delli Carpini","year":"2024","journal-title":"Curr. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.035_bb0255","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ygyno.2018.05.022","article-title":"Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: an NRG oncology group\/gynecologic oncology group study","volume":"150","author":"Ahmed","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.035_bb0260","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2020.11.021","article-title":"Advanced ovarian cancer and cytoreductive surgery: independent validation of a risk-calculator for perioperative adverse events","volume":"160","author":"Straubhar","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.035_bb0265","doi-asserted-by":"crossref","first-page":"1052628","DOI":"10.3389\/fonc.2022.1052628","article-title":"Nomogram to predict postoperative complications after cytoreductive surgery for advanced epithelial ovarian cancer: a multicenter retrospective cohort study","volume":"12","author":"Jiang","year":"2022","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2025.03.035_bb0270","first-page":"292","article-title":"Chemotherapy of ovarian cancer in elderly patients","volume":"12","author":"Troso-Sandoval","year":"2015","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.ygyno.2025.03.035_bb0275","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ygyno.2023.03.018","article-title":"The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: an NRG-Oncology\/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study","volume":"173","author":"Sia","year":"2023","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.035_bb0280","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ygyno.2018.11.031","article-title":"Chemotherapy in older adult gynecologic oncology patients: can a phenotypic frailty score predict tolerance?","volume":"152","author":"Hay","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.03.035_bb0285","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ygyno.2020.05.046","article-title":"Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer","volume":"158","author":"Narasimhulu","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.03.035_bb0290","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ygyno.2016.11.033","article-title":"Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - an NRG oncology\/Gynecologic Oncology Group study","volume":"144","author":"von Gruenigen","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.03.035_bb0295","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.critrevonc.2007.12.005","article-title":"A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study","volume":"66","author":"Pignata","year":"2008","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"4","key":"10.1016\/j.ygyno.2025.03.035_bb0300","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1470-2045(14)70049-X","article-title":"Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial","volume":"15","author":"Pignata","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2025.03.035_bb0305","article-title":"A multicenter retrospective study to assess feasibility, safety and efficacy of first-line carboplatin-paclitaxel versus carboplatin monotherapy in a frail, elderly epithelial ovarian cancer population","author":"Merry","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2025.03.035_bb0310","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1016\/S2666-7568(22)00002-2","article-title":"Validation of the geriatric vulnerability score in older patients with ovarian cancer: an analysis from the GCIG-ENGOT-GINECO EWOC-1 study","volume":"3","author":"Falandry","year":"2022","journal-title":"Lancet Healthy Longev."},{"issue":"6","key":"10.1016\/j.ygyno.2025.03.035_bb0315","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/jamaoncol.2021.0696","article-title":"Efficacy and safety of first-line single-agent carboplatin vs carboplatin plus paclitaxel for vulnerable older adult women with ovarian cancer: a GINECO\/GCIG randomized clinical trial","volume":"7","author":"Falandry","year":"2021","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2025.03.035_bb0320","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/IGC.0000000000001221","article-title":"Safety and efficacy of extended bevacizumab therapy in elderly (>\/=70 years) versus younger patients treated for newly diagnosed ovarian cancer in the international ROSiA study","volume":"28","author":"Selle","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.035_bb0325","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ygyno.2016.11.006","article-title":"Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: subgroup analysis of the randomised phase III AURELIA trial","volume":"144","author":"Sorio","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.035_bb0330","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ygyno.2020.05.045","article-title":"The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: a post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma","volume":"159","author":"Colombo","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.03.035_bb0335","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejca.2022.11.029","article-title":"Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged >\/=65 years from the PAOLA-1\/ENGOT-ov25 trial","volume":"181","author":"Sabatier","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2025.03.035_bb0340","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-024-03609-y","article-title":"First-line PARP inhibitor maintenance treatment in ovarian carcinoma for older adult women: a review of the current literature","author":"Masvidal Hernandez","year":"2024","journal-title":"Clin. Transl. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2025.03.035_bb0345","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.annonc.2024.08.2241","article-title":"Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA\/ENGOT-OV26\/GOG-3012 trial","volume":"35","author":"Monk","year":"2024","journal-title":"Ann. Oncol."},{"issue":"23","key":"10.1016\/j.ygyno.2025.03.035_bb0350","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1056\/NEJMoa2216334","article-title":"Dostarlimab for primary advanced or recurrent endometrial cancer","volume":"388","author":"Mirza","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.ygyno.2025.03.035_bb0355","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa2302312","article-title":"Pembrolizumab plus chemotherapy in advanced endometrial cancer","volume":"388","author":"Eskander","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"10434","key":"10.1016\/j.ygyno.2025.03.035_bb0360","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(24)00317-9","article-title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial","volume":"403","author":"Lorusso","year":"2024","journal-title":"Lancet (London, England)"},{"issue":"19","key":"10.1016\/j.ygyno.2025.03.035_bb0365","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1200\/JCO.21.00138","article-title":"Immunotherapy in older adults with cancer","volume":"39","author":"Presley","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2025.03.035_bb0370","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jamaoncol.2019.5241","article-title":"Association between body mass index and overall survival with immune checkpoint inhibitor therapy for advanced non-small cell lung cancer","volume":"6","author":"Kichenadasse","year":"2020","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.03.035_bb0375","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1470-2045(18)30078-0","article-title":"Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis","volume":"19","author":"McQuade","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2025.03.035_bb0380","doi-asserted-by":"crossref","DOI":"10.1177\/10732748241302248","article-title":"Factors influencing immunotherapy outcomes in cancer: sarcopenia and systemic inflammation","volume":"31","author":"Ucgul","year":"2024","journal-title":"Cancer Control"},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.035_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277708","article-title":"Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1\/PD-L1 inhibitors","volume":"18","author":"Makrakis","year":"2023","journal-title":"PLoS ONE"},{"issue":"23","key":"10.1016\/j.ygyno.2025.03.035_bb0390","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1056\/NEJMoa2309169","article-title":"Mirvetuximab soravtansine in FRalpha-positive, platinum-resistant ovarian cancer","volume":"389","author":"Moore","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2025.03.035_bb0395","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1200\/JCO.2024.42.16_suppl.5580","article-title":"Phase 3 MIRASOL (GOG 3045\/ENGOT-ov55) trial: Mirvetuximab soravtansine (MIRV) vs. investigator\u2019s choice chemotherapy (ICC) in older patients with platinum-resistant ovarian cancer (PROC) and high folate receptor-alpha (FR\u03b1) expression","author":"Bello","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.035_bb0400","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1200\/JCO.23.02005","article-title":"Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: primary results from the DESTINY-PanTumor02 phase II trial","volume":"42","author":"Meric-Bernstam","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2025.03.035_bb0405","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/jgs.14979","article-title":"The geriatrics 5M\u2019s: a new way of communicating what we do","volume":"65","author":"Tinetti","year":"2017","journal-title":"J. Am. Geriatr. Soc."},{"issue":"19","key":"10.1016\/j.ygyno.2025.03.035_bb0410","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1200\/JCO.21.00143","article-title":"Surgical considerations for older adults with cancer: a multidimensional, multiphase pathway to improve care","volume":"39","author":"Montroni","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2025.03.035_bb0415","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/jamasurg.2022.8341","article-title":"Association of routine preoperative frailty assessment with 1-year postoperative mortality","volume":"158","author":"Varley","year":"2023","journal-title":"JAMA Surg."},{"issue":"5","key":"10.1016\/j.ygyno.2025.03.035_bb0420","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/jamasurg.2017.5513","article-title":"Association of integrated care coordination with postsurgical outcomes in high-risk older adults: the perioperative optimization of senior health (POSH) initiative","volume":"153","author":"McDonald","year":"2018","journal-title":"JAMA Surg."},{"issue":"4","key":"10.1016\/j.ygyno.2025.03.035_bb0425","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/SLA.0000000000006458","article-title":"Improving surgical care and outcomes in older cancer patients through implementation of a presurgical toolkit (OPTI-Surg)-final results of a phase III cluster randomized trial (Alliance A231601CD)","volume":"280","author":"Chang","year":"2024","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ygyno.2025.03.035_bb0430","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.23.00933","article-title":"Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update","author":"Dale","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2025.03.035_bb0435","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.4158","article-title":"Geriatric assessment-driven intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial","volume":"7","author":"Li","year":"2021","journal-title":"JAMA Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2025.03.035_bb0440","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/s41416-021-01367-0","article-title":"The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO)","volume":"124","author":"Lund","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"10314","key":"10.1016\/j.ygyno.2025.03.035_bb0445","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","article-title":"Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study","volume":"398","author":"Mohile","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.035_bb0450","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/jamaoncol.2019.4728","article-title":"Communication with older patients with cancer using geriatric assessment: a cluster-randomized clinical trial from the National Cancer Institute Community oncology research program","volume":"6","author":"Mohile","year":"2020","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.035_bb0455","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jgo.2020.07.011","article-title":"The impact of a tailored follow-up intervention on comprehensive geriatric assessment in older patients with cancer - a randomised controlled trial","volume":"12","author":"Orum","year":"2021","journal-title":"J. Geriatr. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2025.03.035_bb0460","doi-asserted-by":"crossref","first-page":"e617","DOI":"10.1016\/S2666-7568(22)00169-6","article-title":"Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment in Australia: a multicentre, open-label, randomised controlled trial","volume":"3","author":"Soo","year":"2022","journal-title":"Lancet Healthy Longev."},{"issue":"13","key":"10.1016\/j.ygyno.2025.03.035_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133290","article-title":"Effectiveness of geriatric assessment-driven interventions on survival and functional and nutritional status in older patients with head and neck cancer: a randomized controlled trial (EGeSOR)","volume":"14","author":"Paillaud","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ygyno.2025.03.035_bb0470","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3324\/haematol.2021.278802","article-title":"Randomized controlled trial of geriatric consultation versus standard care in older adults with hematologic malignancies","volume":"107","author":"DuMontier","year":"2022","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.ygyno.2025.03.035_bb0475","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamasurg.2018.1645","article-title":"Effect of exercise and nutrition prehabilitation on functional capacity in esophagogastric cancer surgery: a randomized clinical trial","volume":"153","author":"Minnella","year":"2018","journal-title":"JAMA Surg."},{"issue":"6","key":"10.1016\/j.ygyno.2025.03.035_bb0480","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/jamasurg.2023.0198","article-title":"Effect of multimodal prehabilitation on reducing postoperative complications and enhancing functional capacity following colorectal cancer surgery: the PREHAB randomized clinical trial","volume":"158","author":"Molenaar","year":"2023","journal-title":"JAMA Surg."},{"issue":"3","key":"10.1016\/j.ygyno.2025.03.035_bb0485","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/jamasurg.2019.5474","article-title":"Effect of multimodal prehabilitation vs postoperative rehabilitation on 30-day postoperative complications for frail patients undergoing resection of colorectal cancer: a randomized clinical trial","volume":"155","author":"Carli","year":"2020","journal-title":"JAMA Surg."},{"key":"10.1016\/j.ygyno.2025.03.035_bb0490","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2022-003652","article-title":"A multimodal prehabilitation program for the reduction of post-operative complications after surgery in advanced ovarian cancer under an ERAS pathway: a randomized multicenter trial (SOPHIE)","author":"Diaz-Feijoo","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.035_bb0495","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12957-022-02517-1","article-title":"Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: a pilot study","volume":"20","author":"Miralpeix","year":"2022","journal-title":"World J. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2025.03.035_bb0500","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/ijgc-2023-004531","article-title":"The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial design","volume":"33","author":"Inci","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2025.03.035_bb0505","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054091","article-title":"Randomised controlled trial testing the feasibility of an exercise and nutrition intervention for patients with ovarian cancer during and after first-line chemotherapy (BENITA-study)","volume":"12","author":"Maurer","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ygyno.2025.03.035_bb0510","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2147\/CIA.S78698","article-title":"The influence of age on health valuations: the older olds prefer functional independence while the younger olds prefer less morbidity","volume":"10","author":"Hofman","year":"2015","journal-title":"Clin. Interv. Aging"},{"issue":"3","key":"10.1016\/j.ygyno.2025.03.035_bb0515","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejso.2020.01.003","article-title":"Functional recovery in senior adults undergoing surgery for colorectal cancer: assessment tools and strategies to preserve functional status","volume":"46","author":"Ghignone","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2025.03.035_bb0520","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jgo.2020.06.006","article-title":"Functional recovery in older women undergoing surgery for gynaecological malignancies: a systematic review and narrative synthesis","volume":"11","author":"Martin","year":"2020","journal-title":"J. Geriatr. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2025.03.035_bb0525","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/jnci\/djac071","article-title":"Quality of life in older adults after major cancer surgery: the GOSAFE international study","volume":"114","author":"Montroni","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.ygyno.2025.03.035_bb0530","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.3754","article-title":"Patient-centered time-at-home outcomes in older adults after surgical cancer treatment","volume":"155","author":"Chesney","year":"2020","journal-title":"JAMA Surg."},{"issue":"9","key":"10.1016\/j.ygyno.2025.03.035_bb0535","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.16747","article-title":"Association of prediagnostic frailty, change in frailty status, and mortality after cancer diagnosis in the women\u2019s health initiative","volume":"3","author":"Cespedes Feliciano","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.ygyno.2025.03.035_bb0540","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/cncr.35075","article-title":"Efficacy-effectiveness gaps in oncology: looking beyond survival","volume":"130","author":"Wilson","year":"2024","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2025.03.035_bb0545","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_100039","article-title":"Common sense oncology: equity, value, and outcomes that matter","volume":"44","author":"Wilson","year":"2024","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"34","key":"10.1016\/j.ygyno.2025.03.035_bb0550","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1200\/JCO.23.01337","article-title":"Evidence-based care of older adults with metastatic colorectal cancer: insights from landmark clinical trials","volume":"41","author":"Ioffe","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"34","key":"10.1016\/j.ygyno.2025.03.035_bb0555","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1200\/JCO.23.00506","article-title":"Initial panitumumab plus fluorouracil, leucovorin, and oxaliplatin or plus fluorouracil and leucovorin in elderly patients with RAS and BRAF wild-type metastatic colorectal cancer: the PANDA trial by the GONO foundation","volume":"41","author":"Lonardi","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2025.03.035_bb0560","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2020.1250","article-title":"Low-dose erlotinib treatment in elderly or frail patients with EGFR mutation-positive non-small cell lung cancer: a multicenter phase 2 trial","volume":"6","author":"Miyamoto","year":"2020","journal-title":"JAMA Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2025.03.035_bb0565","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2019.6828","article-title":"Comparison of carboplatin plus pemetrexed followed by maintenance pemetrexed with docetaxel monotherapy in elderly patients with advanced nonsquamous non-small cell lung cancer: a phase 3 randomized clinical trial","volume":"6","author":"Okamoto","year":"2020","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2025.03.035_bb0570","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/jamaoncol.2023.6277","article-title":"Immunotherapy or chemoimmunotherapy in older adults with advanced non-small cell lung cancer","volume":"10","author":"Tsukita","year":"2024","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.03.035_bb0575","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1470-2045(18)30083-4","article-title":"Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force\/Breast Cancer Group","volume":"19","author":"Wildiers","year":"2018","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2025.03.035_bb0580","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/DCR.0000000000002410","article-title":"The American Society of Colon and Rectal Surgeons clinical practice guidelines for the perioperative evaluation and management of frailty among older adults undergoing colorectal surgery","volume":"65","author":"Saur","year":"2022","journal-title":"Dis. Colon Rectum"},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.035_bb0585","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2019.04.683","article-title":"Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center","volume":"154","author":"Filippova","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.03.035_bb0590","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ageing\/afw039","article-title":"Development and validation of an electronic frailty index using routine primary care electronic health record data","volume":"45","author":"Clegg","year":"2016","journal-title":"Age Ageing"},{"issue":"7","key":"10.1016\/j.ygyno.2025.03.035_bb0595","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/gerona\/glx229","article-title":"Measuring frailty in medicare data: development and validation of a claims-based frailty index","volume":"73","author":"Kim","year":"2018","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"12","key":"10.1016\/j.ygyno.2025.03.035_bb0600","article-title":"Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS study","volume":"3","author":"Feliciano","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ygyno.2025.03.035_bb0605","doi-asserted-by":"crossref","DOI":"10.2196\/47346","article-title":"Use of artificial intelligence in the identification and diagnosis of frailty syndrome in older adults: scoping review","volume":"25","author":"Velazquez-Diaz","year":"2023","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.ygyno.2025.03.035_bb0610","doi-asserted-by":"crossref","DOI":"10.1159\/000540494","article-title":"Integrating AI-driven wearable technology in oncology decision making: a narrative review","author":"Birla","year":"2024","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.ygyno.2025.03.035_bb0615","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/s41598-024-53025-z","article-title":"Harnessing physical activity monitoring and digital biomarkers of frailty from pendant based wearables to predict chemotherapy resilience in veterans with cancer","volume":"14","author":"Cay","year":"2024","journal-title":"Sci. Rep."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582500112X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582500112X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:28:47Z","timestamp":1777955327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082582500112X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":123,"alternative-id":["S009082582500112X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.03.035","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding frailty and the role of patient-centered care for older adults with gynecologic cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.03.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}